Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012

Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012

Canada In Vitro Diagnostics Investment Opportunities Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Canada In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the In In vitro diagnostic dvices in Canada

Scope

• The report provides in vitro diagnostics information broken down into detailed categories and segments in Canada.
• Total revenues, end users
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the in vitro diagnostics devices market in Canada.
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table Of Contents
1 Table Of Contents 2
1.1 List of Tables 10
1.2 List of Figures 13
2 Introduction 15
2.1 What Is This Report About? 15
3 Definitions of Markets Covered in the Report 16
3.1 In Vitro Diagnostics Devices 16
3.2 Clinical Chemistry Test Reagents 16
3.2.1 Laboratory Reagents 16
3.2.2 Clinical Chemistry Calibrators and Controls 16
3.2.3 Clinical Chemistry Rapid Tests 16
3.3 Immunochemistry Test Reagents 16
3.3.1 Disease Specific Markers 16
3.3.2 Disease Specific Test Reagents 17
3.3.3 Drug Related Testing Reagents 17
3.3.4 Hormone Related Testing Reagents 18
3.3.5 Immunochemistry Calibrators and Controls 18
3.3.6 Immunochemistry Rapid Tests 18
3.4 Blood Test Reagents 19
3.4.1 Hematology Test Reagents 19
3.4.2 Hemostasis Test Reagents 19
3.4.3 Tissue Typing Reagents 20
3.4.4 Monoclonal Antibodies 20
3.4.5 Cytokines and Immunomodulators 20
3.4.6 Histology and Cytology Reagents 20
3.5 Microbiology Test Reagents 20
3.5.1 Bacteriology Test Reagents 20
3.5.2 Microbiology Calibrators and Controls 21
3.5.3 Microbiology Rapid Tests 21
3.6 Infectious Immunology Test Reagents 21
3.6.1 Bacteriology 21
3.6.2 Virology 21
3.6.3 Parasitology 22
3.6.4 Infectious Immunology Calibrators and Controls 22
3.6.5 Infectious Immunology Rapid Tests 22
3.7 Genetic Test Reagents 22
3.8 Self Testing 22
3.9 Instruments 22
4 Healthcare Sector Review 23
4.1 Healthcare Expenditure 23
4.2 Healthcare Infrastructure 26
4.3 Healthcare Policy 29
4.4 Canada Healthcare Trade Statistics 30
5 Regulation System 31
5.1 Medical Equipment Approval Process 31
5.1.1 Classification 31
5.1.2 Conformity Assessment 32
5.1.3 License Fee 33
5.1.4 License Application Processing Duration 33
5.2 Labeling and Packaging 34
5.3 Post-Market Surveillance 34
6 Pricing and Reimbursement 35
7 Distribution Structure 36
7.1 Distribution Structure 36
8 Canada Medical Equipment Cross Market Comparison 37
9 In Vitro Diagnostics In Canada 39
9.1 In Vitro Diagnostics Cross Country Comparison (2000-2012) 39
9.2 In Vitro Diagnostics, Canada, Overall Revenues, 2000-2012 40
9.3 In Vitro Diagnostics, Canada, Company Share (2006-2007) 46
10 Blood Test Reagents In Canada 47
10.1 Blood Test Reagents Overall Revenue (2000-2012) 47
10.1.1 Haematology Test Reagents Revenue (2000-2012) 50
10.1.2 Hemostasis Test Reagents Revenue (2000-2012) 52
10.2 Blood Test Reagents Distribution Share (2006-2007) 54
10.3 Blood Test Reagents, Canada, Company Share (2006-2007) 55
11 Clinical Chemistry Test Reagents In Canada 56
11.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2012) 56
11.2 Clinical Chemistry Test Reagents Distribution Share (2006-2007) 58
11.3 Clinical Chemistry Test Reagents, Canada, Company Share (2006-2007) 59
12 Genetic Test Reagents In Canada 60
12.1 Genetic Test Reagents Overall Revenue (2000-2012) 60
12.2 Genetic Test Reagents Distribution Share (2006-2007) 62
12.3 Genetic Test Reagents, Canada, Company Share (2006-2007) 63
13 Immunochemistry Test Reagents In Canada 64
13.1 Immunochemistry Test Reagents Overall Revenue (2000-2012) 64
13.1.1 Disease Specific Markers Revenue (2000-2012) 67
13.1.2 Disease Specific Test Reagents Revenue (2000-2012) 69
13.1.3 Drug Related Testing Reagents Revenue (2000-2012) 71
13.1.4 Hormone Related Testing Reagents Revenue (2000-2012) 73
13.2 Immunochemistry Test Reagents Distribution Share (2006-2007) 75
13.3 Immunochemistry Test Reagents, Canada, Company Share (2006-2007) 76
14 Infectious Immunology Test Reagents In Canada 77
14.1 Infectious Immunology Test Reagents Overall Revenue (2000-2012) 77
14.1.1 Virology Revenue (2000-2012) 79
14.2 Infectious Immunology Test Reagents Distribution Share (2006-2007) 81
14.3 Infectious Immunology Test Reagents, Canada, Company Share (2006-2007) 82
15 Instruments In Canada 83
15.1 Instruments Overall Revenue (2000-2012) 83
15.2 Instruments Distribution Share (2006-2007) 85
15.3 Instruments, Canada, Company Share (2006-2007) 86
16 Microbiology Test Reagents In Canada 87
16.1 Microbiology Test Reagents Overall Revenue (2000-2012) 87
16.1.1 Bacteriology Test Reagents Revenue (2000-2012) 89
16.2 Microbiology Test Reagents Distribution Share (2006-2007) 91
16.3 Microbiology Test Reagents, Canada, Company Share (2006-2007) 92
17 Self Testing In Canada 93
17.1 Self Testing Overall Revenue (2000-2012) 93
17.2 Self Testing Distribution Share (2006-2007) 95
17.3 Self Testing, Canada, Company Share (2006-2007) 96
18 F. Hoffmann-La Roche Ltd. Company Profile 97
18.1 Company Overview 97
18.2 Value Chain Analysis 97
18.2.1 Manufacturing 97
18.2.2 Product Development 98
18.2.3 Sales and Marketing 99
19 Beckman Coulter, Inc. Company Profile 100
19.1 Company Overview 100
19.2 Value Chain Analysis 100
19.2.1 Manufacturing 101
19.2.2 Product Development 101
19.2.3 Sales and Marketing 101
19.3 Beckman Coulter, Inc. Pipeline Products 102
19.3.1 Beckman Coulter, Inc. Pipeline Products by Equipment Type 102
19.3.2 Beckman Coulter, Inc. Pipeline Products by Development Stage 103
19.3.3 Beckman Coulter, Inc. Pipeline Products by Therapy Area 104
19.3.4 Beckman Coulter, Inc. Pipeline Products by News Summary 104
20 Dade Behring Holdings, Inc. Company Profile 105
20.1 Company Overview 105
20.2 Dade Behring Holdings, Inc. Pipeline Products 105
20.2.1 Dade Behring Holdings, Inc. Pipeline Products by Equipment Type 105
20.2.2 Dade Behring Holdings, Inc. Pipeline Products by Development Stage 105
20.2.3 Dade Behring Holdings, Inc. Pipeline Products by Therapy Area 105
20.2.4 Dade Behring Holdings, Inc. Pipeline Products by News Summary 105
21 Abbott Laboratories Company Profile 106
21.1 Company Overview 106
21.2 Value Chain Analysis 106
21.2.1 Manufacturing 107
21.2.2 Product Development 107
21.2.3 Sales and Marketing 108
21.3 Abbott Laboratories Pipeline Products 108
21.3.1 Abbott Laboratories Pipeline Products by Equipment Type 108
21.3.2 Abbott Laboratories Pipeline Products by Development Stage 108
21.3.3 Abbott Laboratories Pipeline Products by Therapy Area 109
21.3.4 Abbott Laboratories Pipeline Products by Clinical Trials 109
21.3.5 Abbott Laboratories Pipeline Products by News Summary 109
22 Siemens Medical Solutions Company Profile 110
22.1 Company Overview 110
22.2 Value Chain Analysis 110
22.2.1 Manufacturing 111
22.2.2 Product Development 111
22.2.3 Sales and Marketing 111
22.3 Siemens Medical Solutions Pipeline Products 112
22.3.1 Siemens Medical Solutions Pipeline Products by Equipment Type 112
22.3.2 Siemens Medical Solutions Pipeline Products by Development Stage 112
22.3.3 Siemens Medical Solutions Pipeline Products by Therapy Area 113
22.3.4 Siemens Medical Solutions Pipeline Products by News Summary 113
23 bioMerieux S.A. Company Profile 114
23.1 Company Overview 114
23.2 Value Chain Analysis 114
23.2.1 Manufacturing 115
23.2.2 Product Development 115
23.2.3 Sales and Marketing 116
24 Affinity Biologicals Incorporated Company Profile 117
24.1 Company Overview 117
25 Biocore Systems Inc. Company Profile 118
25.1 Company Overview 118
26 bioLytical Laboratories Inc. Company Profile 119
26.1 Company Overview 119
26.2 bioLytical Laboratories Inc. Pipeline Products 119
26.2.1 bioLytical Laboratories Inc. Pipeline Products by Equipment Type 119
26.2.2 bioLytical Laboratories Inc. Pipeline Products by Development Stage 119
26.2.3 bioLytical Laboratories Inc. Pipeline Products By Therapy Area 119
26.2.4 bioLytical Laboratories Inc. Pipeline Products By Clinical Trials 120
26.2.5 bioLytical Laboratories Inc. Pipeline Products By News Summary 120
27 Biomedica Diagnostics Inc. Company Profile 121
27.1 Company Overview 121
28 Cedarlane Laboratories Limited Company Profile 122
28.1 Company Overview 122
29 Diagnostics Chemicals Limited Company Profile 123
29.1 Company Overview 123
30 DRAXIMAGE Company Profile 124
30.1 Company Overview 124
31 Medicorp Inc. Company Profile 125
31.1 Company Overview 125
32 Medmira Inc. Company Profile 126
32.1 Company Overview 126
33 Financial Deals Landscape 127
33.1 Acquisition 127
33.1.1 Roche To Acquire ARIUS Research 127
33.2 Venture Financing 129
33.2.1 Adnavance Technologies Secures $5.47 Million In Series B Financing 129
34 Recent Developments 132
34.1 Strategy and Business Planning 132
34.1.1 Mar 04, 2008: Biotage And McMaster Sign Two Year Extension To Molecular Imaging Development Agreement 132
35 APPENDIX 133
35.1 Global Markets Direct Research Methodology 133
35.2 Coverage 134
35.3 Secondary Research 134
35.4 Primary Research 135
35.5 Models 135
35.6 Forecasts 136
35.7 Expert Panels 136
35.8 Currency Conversion 137
35.9 Contact Us 138
35.10 Disclaimer 138





1.1 List of Tables
Table 1: Number of Physicians by Province in Canada, 2001 and 2005 26
Table 2: Hospital Wards by Specialty in Canada, 2003-2007 27
Table 3: Doctors by Specialty in Canada, 2003-2007 28
Table 4: Canada Healthcare Trade Statistics, 2001-2006 30
Table 5: Medical Equipment Classification in Canada, 2007 31
Table 6: Medical Equipment Licensing Fee in Canada, 2007 33
Table 7: Medical Equipment License Processing Duration in Canada, 2007 33
Table 8: Canada, Medical Equipment Market Comparison 38
Table 9: In Vitro Diagnostics Cross Country Comparison (2000-2012) 39
Table 10: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), 2000-2012 40
Table 11: In Vitro Diagnostics Market, Canada, Portfolio Analysis 41
Table 12: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Historic, 2000-2007 43
Table 13: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Forecast, 2007-2012 45
Table 14: In Vitro Diagnostics, Canada, Company Share by Revenue ($ mn), 2006-2007 46
Table 15: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 48
Table 16: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 49
Table 17: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 50
Table 18: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 51
Table 19: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 52
Table 20: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 53
Table 21: Blood Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007 54
Table 22: Blood Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007 55
Table 23: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 56
Table 24: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 57
Table 25: Clinical Chemistry Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007 58
Table 26: Clinical Chemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007 59
Table 27: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 60
Table 28: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 61
Table 29: Genetic Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007 62
Table 30: Genetic Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007 63
Table 31: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 65
Table 32: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 66
Table 33: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 67
Table 34: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 68
Table 35: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 69
Table 36: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 70
Table 37: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 71
Table 38: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 72
Table 39: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 73
Table 40: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 74
Table 41: Immunochemistry Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007 75
Table 42: Immunochemistry Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007 76
Table 43: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 77
Table 44: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 78
Table 45: Virology, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 79
Table 46: Virology, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 80
Table 47: Infectious Immunology Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007 81
Table 48: Infectious Immunology Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007 82
Table 49: Instruments, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 83
Table 50: Instruments, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 84
Table 51: Instruments, Canada, Distribution Share by Revenue ($ mn), 2006-2007 85
Table 52: Instruments, Canada, Company Share by Revenue ($ mn), 2006-2007 86
Table 53: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 87
Table 54: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 88
Table 55: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 89
Table 56: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 90
Table 57: Microbiology Test Reagents, Canada, Distribution Share by Revenue ($ mn), 2006-2007 91
Table 58: Microbiology Test Reagents, Canada, Company Share by Revenue ($ mn), 2006-2007 92
Table 59: Self Testing, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 93
Table 60: Self Testing, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 94
Table 61: Self Testing, Canada, Distribution Share by Revenue ($ mn), 2006-2007 95
Table 62: Self Testing, Canada, Company Share by Revenue ($ mn), 2006-2007 96
Table 63: Beckman Coulter, Inc. Pipeline Products by Equipment Type 102
Table 64: Beckman Coulter, Inc. Pipeline Products By Development Stage 103
Table 65: Beckman Coulter, Inc. Pipeline Products By Therapy Area 104
Table 66: Beckman Coulter, Inc. Pipeline Products By News Summaries 104
Table 67: Dade Behring Holdings, Inc. Pipeline Products by Equipment Type 105
Table 68: Dade Behring Holdings, Inc. Pipeline Products By Development Stage 105
Table 69: Dade Behring Holdings, Inc. Pipeline Products By Therapy Area 105
Table 70: Dade Behring Holdings, Inc. Pipeline Products By News Summaries 105
Table 71: Abbott Laboratories Pipeline Products by Equipment Type 108
Table 72: Abbott Laboratories Pipeline Products By Development Stage 108
Table 73: Abbott Laboratories Pipeline Products By Therapy Area 109
Table 74: Abbott Laboratories Pipeline Products By Clinical Trials 109
Table 75: Abbott Laboratories Pipeline Products By News Summaries 109
Table 76: Siemens Medical Solutions Pipeline Products by Equipment Type 112
Table 77: Siemens Medical Solutions Pipeline Products By Development Stage 112
Table 78: Siemens Medical Solutions Pipeline Products By Therapy Area 113
Table 79: Siemens Medical Solutions Pipeline Products By News Summaries 113
Table 80: bioLytical Laboratories Inc. Pipeline Products by Equipment Type 119
Table 81: bioLytical Laboratories Inc. Pipeline Products By Development Stage 119
Table 82: bioLytical Laboratories Inc. Pipeline Products By Therapy Area 119
Table 83: bioLytical Laboratories Inc. Pipeline Products By Clinical Trials 120
Table 84: bioLytical Laboratories Inc. Pipeline Products By News Summaries 120
Table 85: Currency Conversion from USD to Local Currency at 2007 Constant Rate 137





1.2 List of Figures
Figure 1: Healthcare Financing in Canada, 2004 24
Figure 2: Healthcare Expenditure in Canada, 2000 - 2006 25
Figure 3: Canada, Medical Equipment Market Comparison,2007 37
Figure 4: In Vitro Diagnostics Cross Country Comparison (2000-2012) 39
Figure 5: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), 2000-2012 40
Figure 6: In Vitro Diagnostics Market, Canada, Portfolio Analysis 41
Figure 7: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Historic, 2000-2007 42
Figure 8: In Vitro Diagnostics, Canada, Overall Revenues ($ mn), Forecast, 2007-2012 44
Figure 9: In Vitro Diagnostics, Canada, Company Share (%), 2007 46
Figure 10: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 47
Figure 11: Blood Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 49
Figure 12: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 50
Figure 13: Haematology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 51
Figure 14: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 52
Figure 15: Hemostasis Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 53
Figure 16: Blood Test Reagents, Canada, Company Share (%), 2007 55
Figure 17: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 56
Figure 18: Clinical Chemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 57
Figure 19: Clinical Chemistry Test Reagents, Canada, Company Share (%), 2007 59
Figure 20: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 60
Figure 21: Genetic Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 61
Figure 22: Genetic Test Reagents, Canada, Company Share (%), 2007 63
Figure 23: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 64
Figure 24: Immunochemistry Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 66
Figure 25: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 67
Figure 26: Disease Specific Markers, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 68
Figure 27: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 69
Figure 28: Disease Specific Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 70
Figure 29: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 71
Figure 30: Drug Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 72
Figure 31: Hormone Related Testing Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 74
Figure 32: Immunochemistry Test Reagents, Canada, Company Share (%), 2007 76
Figure 33: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 77
Figure 34: Infectious Immunology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 78
Figure 35: Virology, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 79
Figure 36: Virology, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 80
Figure 37: Infectious Immunology Test Reagents, Canada, Company Share (%), 2007 82
Figure 38: Instruments, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 83
Figure 39: Instruments, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 84
Figure 40: Instruments, Canada, Company Share (%), 2007 86
Figure 41: Microbiology Test Reagents, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 88
Figure 42: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 89
Figure 43: Bacteriology Test Reagents, Canada, Revenues ($ mn) by Sub-Segment, Forecast,, 2007-2012 90
Figure 44: Microbiology Test Reagents, Canada, Company Share (%), 2007 92
Figure 45: Self Testing, Canada, Revenue ($ mn) by Segment, Historic, 2000-2007 93
Figure 46: Self Testing, Canada, Revenue ($ mn) by Segment, Forecast, 2007-2012 94
Figure 47: Self Testing, Canada, Company Share (%), 2007 96
Figure 48: F. Hoffmann-La Roche Ltd Value Chain Analysis 97
Figure 49: Beckman Coulter, Inc. Value Chain Analysis 100
Figure 50: Abbott Laboratories Value Chain Analysis 106
Figure 51: Siemens Medical Solutions Value Chain Analysis 110
Figure 52: Biomerieux Sa Value Chain Analysis 114
Figure 53: Global Markets Direct Methodology 133